Taro Pharmaceutical EPS beats by $0.22, misses on revenue
Feb. 03, 2020 5:25 PM ETTaro Pharmaceutical Industries Ltd. (TARO)By: Pranav Ghumatkar, SA News Editor
- Taro Pharmaceutical (NYSE:TARO): Q3 GAAP EPS of $1.76 beats by $0.22.
- Revenue of $147.68M (-8.2% Y/Y) misses by $24.33M.
- Press Release